CompletedNot Applicable

ARC in Hemorrhagic Stroke

United States80 participantsStarted 2015-01

Plain-language summary

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults ≥ 18 years * Patients with hemorrhagic stroke * Anticipated length of stay in the neuroscience intensive care unit \> 48 hours * Informed consent provided by the patient or by the patient's designated medical proxy Exclusion Criteria: * Pregnancy * Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5) * Patients receiving renal replacement therapy * Patients with an admission serum creatinine \> 1.4 mg/dL * Patients with non-aneurysmal subarachnoid hemorrhage * Patients with history of nephrectomy or body mass index \< 18 kg/m2

What they're measuring

To describe the onset, magnitude, and change over time of ARC in patients with hemorrhagic stroke

Timeframe: Over neurosciences intensive care unit stay

Trial details

NCT IDNCT02386202

SponsorUniversity of North Carolina, Chapel Hill

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-08

View on ClinicalTrials.gov More Hemorrhagic Stroke trials